Bernd Wicklein

Dr. Bernd Wicklein

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 November 2014 in Nature Nanotechnology
Verified
Journal Article
Closed access
BWBernd Wicklein
Bernd Wicklein
Andraž KocjanAndraž Kocjan
Andraž Kocjan
GSGerman Salazar-Alvarez
German Salazar-Alvarez
Federico CarosioFederico Carosio
Federico Carosio
GCGiovanni Camino
Giovanni Camino
LBLennart Bergström
Lennart Bergström

1 October 2013 in Progress in Polymer Science
Verified
Journal Article
Closed access
EREduardo Ruiz-Hitzky
Eduardo Ruiz-Hitzky
MDMargarita Darder
Margarita Darder
FFFrancisco M. Fernandes
Francisco M. Fernandes
BWBernd Wicklein
Bernd Wicklein
Ana AlcantaraAna Alcantara
Ana Alcantara
PAPilar Aranda
Pilar Aranda

3 September 2020 in Advanced Healthcare Materials
Verified
Journal Article
Open access
PDF file
EREduardo Ruiz-Hitzky
Eduardo Ruiz-Hitzky
MDMargarita Darder
Margarita Darder
BWBernd Wicklein
Bernd Wicklein
CRCristina Ruiz-Garcia
Cristina Ruiz-Garcia
RMRaquel Martín‐Sampedro
Raquel Martín‐Sampedro
PAPilar Aranda
Pilar Aranda
Researchers, engineers, and medical doctors are made aware of the severity of the COVID‐19 infection and act quickly against the coronavirus SARS‐CoV‐2 using a large variety of tools. In this review, a panoply of nanoscience and nanotechnology approaches show how these disciplines can help the medical, technical, and scientific communities to fight the pandemic, highlighting the development of nanomaterials for detection, sanitation, therapies, and vaccines. SARS‐CoV‐2, which can be regarded as a functional core–shell nanoparticle (NP), can interact with diverse materials in its vicinity and remains attached for variable times while preserving its bioactivity. These studies are critical for the appropriate use of controlled disinfection systems. Other nanotechnological approaches are also decisive for the development of improved novel testing and diagnosis kits of coronavirus that are urgently required. Therapeutics are based on nanotechnology strategies as well and focus on antiviral drug design and on new nanoarchitectured vaccines. A brief overview on patented work is presented that emphasizes nanotechnology applied to coronaviruses. Finally, some comments are made on patents of the initial technological responses to COVID‐19 that have already been put in practice.

21 March 2016 in Chemistry of Materials
Verified
Journal Article
Closed access
BWBernd Wicklein
Bernd Wicklein
DKDarko Kocjan
Darko Kocjan
Federico CarosioFederico Carosio
Federico Carosio
GCGiovanni Camino
Giovanni Camino
LBLennart Bergström
Lennart Bergström

6 February 2018 in Nanoscale
Verified
Journal Article
Open access
PDF file
MGMaryam Ghanadpour
Maryam Ghanadpour
BWBernd Wicklein
Bernd Wicklein
Federico CarosioFederico Carosio
Federico Carosio
LWLars Wågberg
Lars Wågberg
Pure cellulosic foams suffer from low thermal stability and high flammability, limiting their fields of application.

25 January 2010 in Langmuir
Verified
Journal Article
Closed access
BWBernd Wicklein
Bernd Wicklein
MDMargarita Darder
Margarita Darder
PAPilar Aranda
Pilar Aranda
EREduardo Ruiz-Hitzky
Eduardo Ruiz-Hitzky